Exercise interventions on health related quality of life for people with cancer during active treatment

  • Protocol
  • Intervention

Authors

  • Shiraz I Mishra,

    Corresponding author
    1. University of Maryland School of Medicine, Department of Family and Community Medicine and Office of Policy and Planning, Baltimore, Maryland, USA
    • Shiraz I Mishra, Department of Family and Community Medicine and Office of Policy and Planning, University of Maryland School of Medicine, 685 W. Baltimore Street, Suite 610, Baltimore, Maryland, 21201, USA. smishra@som.umaryland.edu.

    Search for more papers by this author
  • Roberta W Scherer,

    1. Johns Hopkins University Bloomberg School of Public Health, Center for Clinical Trials, Baltimore, Maryland, USA
    Search for more papers by this author
  • Noreen M Aziz,

    1. National Cancer Institute, Office of Cancer Survivorship, Bethesda, Maryland, USA
    Search for more papers by this author
  • Carolyn C Gotay,

    1. Faculty of Medicine, University of British Columbia, Primary Cancer Prevention Department of Health Care and Epidemiology, Vancouver, British Columbia, Canada
    Search for more papers by this author
  • Claudia R Baquet,

    1. University of Maryland School of Medicine, Department of Medicine and Office of Policy and Planning, Baltimore, Maryland, USA
    Search for more papers by this author
  • Debra R Berlanstein,

    1. University of Maryland, Baltimore, Health Sciences & Human Services, Baltimore, USA
    Search for more papers by this author
  • Paula M Geigle

    1. University of Maryland School of Medicine, Department of Physical Therapy & Rehabilitation Science, Baltimore, Maryland, USA
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the effectiveness of exercise on overall HRQoL outcomes and specific HRQoL domains (e.g. physical, psychological, economic, social, and spiritual well-being, and key disease and/or treatment symptoms such as sexual functioning, neuropathy or cognitive changes, and chronic fatigue) among adult persons with cancer during active treatment (excluding those who are terminally ill and receiving hospice).

A secondary objective is to examine the effectiveness of exercise on HRQoL outcomes among adult persons with cancer who are undergoing active treatment by the following:

  1. Age at diagnosis (i.e. less than 65 years or greater than or equal to 65 years);

  2. Age at trial enrolment (i.e. less than 65 years or greater than or equal to 65 years);

  3. Sex;

  4. Type of prescribed exercise (i.e. aerobic, anaerobic, combination);

  5. Intensity of exercise (i.e. mild, moderate, vigorous);

  6. Format of exercise (i.e. individual or group, professionally led or not, home or group facility);

  7. Type of treatment regimen (i.e. radiation, surgery, chemotherapy, or combination); and

  8. Specific chemotherapeutic agents